4.6 Review

IAPs, regulators of innate immunity and inflammation

Journal

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Volume 39, Issue -, Pages 106-114

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcdb.2014.03.035

Keywords

TNF; RIG-I; TLR; NOD; IAP

Funding

  1. Methusalem grant [BOF09/01M00709]
  2. European grants (Euregional PACT II)
  3. Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]
  4. Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, FWO G.0172.12N, FWO G0787.13N]
  5. Ghent University grants (MRP)
  6. VIB

Ask authors/readers for more resources

As indicated by their name, members of the Inhibitor of APoptosis (IAP) family were first believed to be functionally restricted to apoptosis inhibition. It is now clear that IAPs have a much wider spectrum of action, and recent studies even suggest that some of its members primarily regulate inflammatory responses. Inflammation, the first response of the immune system to infection or tissue injury, is highly regulated by ubiquitylation - a posttranslational modification of proteins with various consequences. In this review, we focus on the recently reported functions of XIAP, cIAP1 and cIAP2 as ubiquitin ligases regulating innate immunity and inflammation. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available